dr. petrylak discusses the isotope radium-223
Published 12 years ago • 449 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
6:25
dr. george discusses radium-223 for patients with mcrpc part i
-
4:42
dr. george discusses radium-223 for patients with mcrpc part ii
-
1:25
dr. sartor discusses the novel agent radium-223
-
1:43
dr. petrylak discusses sequencing prostate cancer therapies
-
1:08
dr. finkelstein summarizes the development of radium-223
-
1:08
dr. daniel petrylak explains the correlation between immune response to sipuleucel-t and survival
-
0:53
dr. higano on combinations with radium-223 for prostate cancer
-
0:55
dr. sartor on patients in the alsympca radium-223 trial
-
4:46
breakthrough: the 3 metabolites driving disease dr. richard nkwenti ph.d's metabolic trinity theory
-
47:15
electrochemical graphene production
-
6:20
asdex upgrade: researching the energy of the future (in 4k / uhd)
-
0:47
dr. daniel petrylak describes the clinical investigation of prostvac in prostate cancer
-
1:08
dr. a. oliver sartor on the mechanism of action of radium-223
-
0:44
dr. petrylak on the results of the phase ii stride study
-
0:41
dr. daniel petrylak discusses the future of abiraterone acetate
-
3:56
bone-targeted therapy for prostate cancer: radium-223
-
0:34
dr. petrylak discusses custirsen as a potential treatment for prostate cancer
-
1:49
dr. nicholas vogelzang discusses radium-223 in prostate cancer
-
1:10
dr. dreicer on challenges of radium-223 in prostate cancer
-
1:10
dr. daniel petrylak discusses chemotherapy in prostate cancer
-
0:53
dr. shore discusses patient considerations with radium-223
-
1:21
dr. petrylak explains prostate cancer clinical trial difficulties